Bellevue Group’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
Bellevue Group's BLUE Position: Q2 2020 in Review
Bellevue Group sold out of bluebird bio (BLUE) in Q2 2020, closing a stake of 1,529 shares — an estimated $910K sold.
Bellevue Group first reported a position in BLUE in Q1 2016 and held it in 16 quarters. The position peaked at $3.63M in Q1 2019. 278 funds tracked by Wall St. Rank hold BLUE as of Q2 2020.
- Bellevue Group reported no remaining bluebird bio position as of Q2 2020 after selling out during the quarter.
- Bellevue Group sold 1,529 bluebird bio shares in Q2 2020, an estimated $910K.
- Bellevue Group first reported a position in bluebird bio in Q1 2016 and held it in 16 quarters.
- Bellevue Group's bluebird bio position peaked at $3.63M in Q1 2019.
- 278 funds tracked by Wall St. Rank held bluebird bio as of Q2 2020.
Based on Bellevue Group's 13F filing for Q2 2020, filed 13 Aug 2020.